Ifosfamide nephropathy in patients with sarcoma

Iranian Journal of Kidney Diseases

Volumn 5, Issue 4, 2011, Pages 238-241

  Mashhadi, Mohammad Ali ^a   Sanadgol, Houshang ^a   Keikhaei, Mahmoudali ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glycosuria; Ifosfamide; Proteinuria; Sarcoma

Indexed keywords

DOXORUBICIN; ETOPOSIDE; GRANISETRON; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CANCER PATIENT; CHILD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSURIA; HEMATURIA; HUMAN; HYPOPHOSPHATEMIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PRESCHOOL CHILD; PROTEINURIA; RHABDOMYOSARCOMA; SARCOMA; SCHOOL CHILD; SIDE EFFECT; SOFT TISSUE SARCOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; INCIDENCE; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; SARCOMA; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; YOUNG ADULT;

EID: 79959847021     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mashhadi MA. Renal side effect of ifosfamide, in patients admitted for chemotherapy. J Res Med Sci. 2008;13: 240-243.
2. Skinner R. Chronic ifosfamide nephrotoxicity in children. Med Pediatr Oncol. 2003;41:190-197.
3. Stohr W, Paulides M, Bielack S, et al. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Pediatr Blood Cancer. 2007;48:447-452.
4. Nissim I, Weinberg JM. Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats. Kidney Int. 1996;49:684-695.
5. Stuart-Harris RC, Harper PG, Parsons CA, et al. Highdose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma. Cancer Chemother Pharmacol. 1983;11:69-72.
6. Marina NM, Poquette CA, Cain AM, Jones D, Pratt CB, Meyer WH. Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas. J Pediatr Hematol Oncol. 2000;22:112-118.
7. Rossi R, Godde A, Kleinebrand A, et al. Unilateral nephrectomy and cisplatin as risk factors of ifosfamideinduced nephrotoxicity: analysis of 120 patients. J Clin Oncol. 1994;12:159-165.
8. National Cancer Institute [homepage on the internet]. Cancer Therapy Evaluation Program: Common Terminology Criteria for Adverse Events. Version 3.0 [cited Feb 2, 2003]. Available from: http://ctep.cancer. gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_30
9. McCune JS, Friedman DL, Schuetze S, Blough D, Magbulos M, Hawkins DS. Influence of age upon Ifosfamide-induced nephrotoxicity. Pediatr Blood Cancer. 2004;42:427-432.
10. Springate J, Taub M. Ifosfamide toxicity in cultured proximal renal tubule cells. Pediatr Nephrol. 2007;22: 358-365.
11. Rossi R, Pleyer J, Schafers P, et al. Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients. Med Pediatr Oncol. 1999;32:177-182.
12. Skinner R, Cotterill SJ, Stevens MC. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group. Br J Cancer. 2000;82:1636-1645.
13. Lee BS, Lee JH, Kang HG, et al. Ifosfamide nephrotoxicity in pediatric cancer patients. Pediatr Nephrol. 2001;16: 796-799.
14. Loebstein R, Atanackovic G, Bishai R, et al. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol. 1999;39: 454-461.
15. Ferrari S, Pieretti F, Verri E, et al. Prospective evaluation of renal function in pediatric and adult patients treated with high-dose ifosfamide, cisplatin and high-dose methotrexate. Anticancer Drugs. 2005;16:733-738.
16. Mashhadi MA. The effect of high dose methotrexate in patients with neoplastic disease. Iran Red Crescent Med J. 2008;10:75-78.